Skip to main content
. 2023 May 9;15:94. doi: 10.1186/s13098-023-01012-1

Table 3.

Demographic and clinical characteristics of participants by TyG

TyG 1 TyG 2 TyG 3 TyG 4 P
Age (years) 58.11 ± 10.94 57.74 ± 11.55 60.03 ± 11.86 60.34 ± 12.37 0.034
Gender (male) 139 (61.0) 142 (62.3) 138 (60.5) 142 (62.3) 0.972
Smoke [(n%)] 91 (39.9) 92 (40.4) 107 (46.9) 91 (39.9) 0.343
HT [(n%)] 120 (52.6) 123 (53.9) 141 (61.8) 147 (64.5) 0.023
DM [(n%)] 22 (9.6) 50 (21.9) 76 (33.3) 117 (51.3)  < 0.001
CHD [(n%)] 103 (45.2) 112 (49.1) 120 (52.6) 138 (60.5) 0.009
BMI (kg/m2) 25.91 ± 2.65 25.98 ± 2.90 25.85 ± 2.76 26.35 ± 2.90 0.228
SBP (mmHg) 129.89 ± 16.54 132.12 ± 18.32 134.89 ± 19.97 131.41 ± 20.07 0.037
DBP (mmHg) 79.93 ± 12.83 80.60 ± 12.78 80.33 ± 13.56 79.20 ± 13.15 0.688
ALT (U/L) 21.80 (16.00,29.70) 22.55 (16.20,30.68) 26.85 (18.25,34.15) 26.05 (18.70,34.50)  < 0.001
AST (U/L) 21.50 (18.00, 26.10) 22.50 (18.40, 28.30) 23.30 (18.50, 29.28) 23.40 (18.30, 30.60) 0.039
Scr (mmol/L) 67.00 (58.00, 77.00) 67.50 (59.00, 77.00) 65.18 (58.82, 75.92) 68.00 (56.25, 78.00) 0.699
TC (mmol/L) 3.87 (3.26, 4.73) 4.13 (3.57, 5.01) 4.49 (3.64, 5.35) 4.58 (3.75, 5.41)  < 0.001
TG (mmol/L) 1.13 (0.98, 1.27) 1.48 (1.29, 1.71) 1.94 (1.65, 2.20) 2.53 (2.02, 2.98)  < 0.001
HDL-C (mmol/L) 1.19 (1.00, 1.40) 1.08 (0.92, 1.29) 1.05 (0.95, 1.20) 1.02 (0.88, 1.17)  < 0.001
LDL-C (mmol/L) 2.10 (1.56, 2.60) 2.28 (1.89, 2.75) 2.40 (1.87, 2.92) 2.42 (1.85, 2.92)  < 0.001
FBG (mmol/L) 5.06 (4.63, 5.45) 5.39 (4.85, 6.25) 5.72 (5.16,6.90) 7.15 (5.81, 8.59)  < 0.001
Anti-diabetic drugs[(n%)] 16 (7.0) 39 (17.1) 72 (31.6) 109 (47.8)  < 0.001
Lipid-lowering drugs[(n%)] 58 (25.4) 65 (28.5) 73 (32.0) 82 (36.0) 0.084
TyG 8.39 ± 0.20 8.78 ± 0.83 9.09 ± 0.99 9.57 ± 0.27  < 0.001
AF [(n%)] 38 (16.7) 38 (16.7) 520 (22.8) 76 (33.3)  < 0.001

Values are expressed as mean ± standard deviation, no. (%), or median (interquartile range). P < 0.05 (two-sided) was defined as statistically significant